Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Vaccine Production

Vaccine Production

Vaccine production involves a sequence of upstream and downstream processes to generate a safe and effective immunological product. It begins with cultivating microorganisms, such as viruses or bacteria, to obtain antigenic material. For viral vaccines, mammalian host cells are grown in bioreactors and subsequently infected with the target virus. The virus replicates within the host cells, which are lysed to release viral particles. This lysate is then clarified through filtration or...

Vaccinations

Vaccinations

Vaccines

Vaccines

Vaccines are among the most effective tools in preventive medicine, designed to prepare the immune system to recognize and combat infectious agents. By introducing antigens—substances that the immune system identifies as foreign—vaccines stimulate an adaptive immune response that leads to immunological memory. This immunological memory enables the body to mount a faster and more effective response upon future exposures to the actual pathogen.Vaccines can be categorized based on the...

Microorganisms in Medicine and Therapeutics

Microorganisms in Medicine and Therapeutics

Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.

Humoral Immune Responses

Humoral Immune Responses

Development of Immunocompetence

Development of Immunocompetence

The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

R21 in Matrix-M adjuvant in UK malaria-naive adult men and non-pregnant women aged 18-45 years: an open-label, partially blinded, phase 1-2a controlled human malaria infection study.

The Lancet. Microbe·2025

Same author

Evaluation of a novel malaria anti-sporozoite vaccine candidate, R21 in Matrix-M adjuvant, in the UK and Burkina Faso: two phase 1, first-in-human trials.

The Lancet. Microbe·2025

Same author

An integrative network-based approach to identify driving gene communities in chronic obstructive pulmonary disease.

NPJ systems biology and applications·2024

Same author

Use of 3M-052-AF with Alum adjuvant in HIV trimer vaccine induces human autologous neutralizing antibodies.

The Journal of experimental medicine·2024

Same author

MOCHA's advanced statistical modeling of scATAC-seq data enables functional genomic inference in large human cohorts.

Nature communications·2024

Same author

Focusing HIV-1 Gag T cell responses to highly conserved regions by DNA vaccination in HVTN 119.

JCI insight·2024

Search research articles

Related Experiment Video

Updated: May 2, 2026

Evaluation of Host-Pathogen Responses and Vaccine Efficacy in Mice

Evaluation of Host-Pathogen Responses and Vaccine Efficacy in Mice

Published on: February 22, 2019

Challenges and responses in human vaccine development.

Stefan H E Kaufmann¹, M Juliana McElrath², David J M Lewis³

¹Max Planck Institute for Infection Biology, Department of Immunology, Charitéplatz 1, Berlin D-10117, Germany.

Current Opinion in Immunology

|February 25, 2014

Summary

Developing human vaccines is complex due to pathogen evasion. Iterative approaches combining novel discoveries with data analysis accelerate the design of effective vaccines against challenging diseases.

More Related Videos

Whole-animal Imaging and Flow Cytometric Techniques for Analysis of Antigen-specific CD8+ T Cell Responses after Nanoparticle Vaccination

Whole-animal Imaging and Flow Cytometric Techniques for Analysis of Antigen-specific CD8+ T Cell Responses after Nanoparticle Vaccination

Published on: April 29, 2015

Detection of Neutralization-sensitive Epitopes in Antigens Displayed on Virus-Like Particle VLP-Based Vaccines Using a Capture Assay

Detection of Neutralization-sensitive Epitopes in Antigens Displayed on Virus-Like Particle VLP-Based Vaccines Using a Capture Assay

Published on: February 10, 2022

Related Experiment Videos

Last Updated: May 2, 2026

Evaluation of Host-Pathogen Responses and Vaccine Efficacy in Mice

Evaluation of Host-Pathogen Responses and Vaccine Efficacy in Mice

Published on: February 22, 2019

Whole-animal Imaging and Flow Cytometric Techniques for Analysis of Antigen-specific CD8+ T Cell Responses after Nanoparticle Vaccination

Whole-animal Imaging and Flow Cytometric Techniques for Analysis of Antigen-specific CD8+ T Cell Responses after Nanoparticle Vaccination

Published on: April 29, 2015

Detection of Neutralization-sensitive Epitopes in Antigens Displayed on Virus-Like Particle VLP-Based Vaccines Using a Capture Assay

Detection of Neutralization-sensitive Epitopes in Antigens Displayed on Virus-Like Particle VLP-Based Vaccines Using a Capture Assay

Published on: February 10, 2022

Area of Science:

Vaccinology
Immunology
Computational Biology

Background:

Human vaccine development faces significant hurdles due to sophisticated pathogen evasion mechanisms.
Recent vaccine design efforts have yielded both successes and failures, highlighting the need for improved strategies.

Purpose of the Study:

To outline the advancements and iterative approaches in human vaccine design.
To highlight the integration of preclinical discoveries and computational analysis for accelerated vaccine development.

Main Methods:

Utilizing reverse and structural vaccinology to identify novel antigen candidates.
Applying molecular immunology to formulate effective adjuvants.
Analyzing gene expression profiles and immune parameters from patients and controls to establish biosignatures.

Main Results:

Identification of novel antigen candidates through advanced vaccinology techniques.
Development of promising adjuvants based on molecular immunology principles.
Establishment of biosignatures from patient and vaccinee data to guide future vaccine design.

Conclusions:

Iterative approaches combining novel discoveries with computational analysis are crucial for accelerating vaccine design.
Biosignatures derived from immune profiling offer valuable guidelines for future human vaccine development.
Continued innovation in antigen, adjuvant, and vector discovery is essential for overcoming vaccine development challenges.